Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 13.
doi: 10.14309/ajg.0000000000003416. Online ahead of print.

Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated Hepatitis: A Randomized Trial (STASH Trial)

Anand V Kulkarni  1 , Karan Kumar  2 , Suprabhat Giri  3 , Juan Pablo Arab  4   5   6 , Shantan Venishetty  1 , Madhumita Premkumar  7 , Harshith B Kadnur  8 , Mithun Sharma  1 , Manasa Alla  1 , Sowmya Iyengar  1 , Gauri Nayak  1 , Vivek Anand Saraswat  2 , Rajesh Gupta  1 , Padaki Nagaraja Rao  1 , K Rajender Reddy  9 , Duvvur Nageshwar Reddy  1
Affiliations

Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated Hepatitis: A Randomized Trial (STASH Trial)

Anand V Kulkarni et al. Am J Gastroenterol. .

Abstract

Introduction: Current guidance recommends a 40-mg dose of prednisolone (or equivalent) for severe alcohol-associated hepatitis (AAH), while infections are not uncommon in them. The benefits of a rapid prednisolone tapering regimen in mitigating infection in patients with AAH are unknown. The primary objective was to assess the incidence of infection by day 90. The key secondary objectives were the incidence of mortality, acute kidney injury, readmissions rate, and adverse events.

Methods: In this multicenter randomized clinical trial, patients with severe AAH were included from March 15, 2023, to August 28, 2024. Patients were randomly assigned to receive a standard fixed prednisolone dose (40 mg/d) for 4 weeks or 40 mg/d tapered by 10 mg/d every week over 4 weeks.

Results: Two hundred fifty-four patients were enrolled (age: 41.16 ± 8.2 years, 98% men). The incidence of infection on day 90 was 33.1% (42 of 127; 95% confidence interval [CI] 23.8-44.7) in the fixed-dose group compared with 19.7% (25 of 127; 95% CI 16.1-37) in the tapered dose group, with a hazard ratio of 0.57 (95% CI 0.35-0.94; P = 0.03). On competing risk regression analysis after adjustment for relevant covariates, tapered dose of prednisolone was associated with a lower incidence of infection by day 90 (subdistribution hazard ratio 0.34; 95% CI 0.15-0.78; P = 0.01). Nineteen percent (24/127; 95% CI 12.5-26.8) in the fixed-dose group and 8.6% (11/127; 95% CI 4.4-14.9; P = 0.02) in the tapered-dose group had microbiologically proven infections. There were no differences in mortality, acute kidney injury incidence, hospitalizations, or all-cause adverse events.

Discussion: In patients with severe AAH, a tapered prednisolone regimen may mitigate the frequency of infections (CTRI/2023/03/050521).

Keywords: STASH trial; alcohol-associated hepatitis; corticosteroids; infections.

PubMed Disclaimer

References

    1. Bataller R, Arab JP, Shah VH. Alcohol-associated hepatitis. N Engl J Med 2022;387(26):2436–48.
    1. Jophlin LL, Singal AK, Bataller R, et al. ACG clinical guideline: Alcohol-associated liver disease. Am J Gastroenterol 2024;119(1):30–54.
    1. Morales-Arráez D, Ventura-Cots M, Altamirano J, et al. The MELD score is superior to the Maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: A global study. Am J Gastroenterol 2022;117:301–10.
    1. Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015;372(17):1619–28.
    1. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45(6):1348–54.

LinkOut - more resources